The specialty generics market is emerging as a significant segment within the broader pharmaceutical industry, offering cost-effective alternatives to high-priced branded specialty drugs. Specialty generics refer to off-patent versions of complex, high-cost medications used to treat chronic, rare, or complex conditions such as cancer, autoimmune disorders, multiple sclerosis, and HIV. As healthcare systems worldwide seek to control rising drug expenditures while ensuring access to advanced therapies, the demand for specialty generics is poised to accelerate through 2032.
